Author:
Sanchez-Piedra Carlos,Hernández Miguel M. Victoria,Manero Javier,Roselló Rosa,Sánchez-Costa Jesús Tomás,Rodríguez-Lozano Carlos,Campos Cristina,Cuende Eduardo,Fernández-Lopez Jesús Carlos,Bustabad Sagrario,Martín Domenech Raquel,Pérez-Pampín Eva,del Pino-Montes Javier,Millan-Arciniegas Ana Milena,Díaz-González Federico,Gómez-Reino Juan Jesús
Reference29 articles.
1. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases;Gabriel;Arthritis Res Ther.,2009
2. Prevalencia e impacto de las enfermedades reumáticas en la población adulta española;Episer,2001
3. Rheumatology SCoBRUSSo. Annual report. Spanish Registry on adverse events of biological therapies in rheumatic diseases. Madrid: Spanish Society of Rheumatology; 2015.
4. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness;Chen;Health Technol Assess.,2006
5. Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double-blind, placebo-controlled, phase iiitrial;Inman;Arthritis Rheum.,2008
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献